A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis1-Reference-Cited by-同舟云学术

A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis1

Published:2002-06 Issue:6 Volume:97 Page:1398-1407
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Levine Douglas S.,Riff Dennis S.,Pruitt Ronald,Wruble Lawrence,Koval George,Sales David,Bell John K.,Johnson Lorin K.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference19 articles.

1. Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel Disease

2. Absorption, metabolism, and excretion of salicylazosulfapyridine in man

3. AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE

4. Renal tubular dysfunction in patients with inflammatory bowel disease treated with aminosalicylate.

5. Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis;Journal of Clinical Medicine;2022-04-20

2. First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensus;World Journal of Gastroenterology;2020-11-21

3. Outcomes of a drug shortage requiring switching in patients with ulcerative colitis;World Journal of Gastrointestinal Pathophysiology;2020-04-12

4. Efficacy of adjuvant curcumin therapy in ulcerative colitis: A meta‐analysis of randomized controlled trials;Journal of Gastroenterology and Hepatology;2019-11-07

5. Time to clinical response and remission for therapeutics in inflammatory bowel diseases: What should the clinician expect, what should patients be told?;World Journal of Gastroenterology;2017-09-21